INTRODUCTION
Mitogen-activated protein (MAP) kinase pathways are indispensable intracellular cascades that couple signals from cell surface to the nucleus (1, 2) . The three best-characterized MAP kinase cascades are the extracellular signal-regulated protein kinase (ERK) pathway which responds to stimuli that induce cell proliferation and differentiation, the c-Jun N-terminal protein kinase (JNK) pathway, and the p38 kinase pathway, both of which are activated in response to environmental stresses. The MAP kinases are the major convergence points in these signaling pathways. Each MAP kinase phosphorylates a distinct spectrum of substrates, which include key regulatory enzymes, cytoskeletal proteins, regulators of apoptosis, nuclear receptors, and many transcription factors. Such a broad array of substrates is consistent with the observation that MAP kinases control many critical cell functions. Because of the critical importance of MAP kinase in cellular signaling, the activity of the MAP kinase is tightly regulated. The activation of the MAP kinase activity requires the phosphorylation of the Thr and Tyr residues in the activation loop by the dual specificity MAP kinase/ERK kinases (MEKs) (3, 4) . MAP kinase deactivation occurs through the action of multiple protein phosphatases (5) .
Although the importance of MAP kinases in cellular signaling is well established, there is limited understanding of the molecular basis for specific MAP kinase recognition by its activators, inactivators, and substrates. Such knowledge is essential for comprehension of the ability of MAP kinases to integrate diverse biological stimuli and to transmit signals to the nucleus, in order to generate appropriate cellular responses. Recent studies suggest that MAP kinases are capable of forming complexes with their cognate activating kinases, inactivating phosphatases, and substrates (6) (7) (8) . Our previous studies have focused on the interaction between is 10 6 -fold higher than those for the hydrolysis of p-nitrophenyl phosphate (pNPP) or the bisphosphorylated peptide derived from the activation loop of ERK2 (10) . Interestingly, the phosphatase activity of the MKP3-catalyzed pNPP reaction can be dramatically increased when it associates with ERK2 (14) . Mechanistic and kinetic studies suggest that ERK2 binding to MKP3 elicit activation of MKP3 activity by facilitating the repositioning of active site residues and general acid loop closure in MKP3 (9, 10, 15) .
To identify structural features in MKP3 that are important for ERK2 binding and ERK2-induced activation, we carried out a systematic mutational and deletion analysis of MKP3 (11) .
Since the activation of MKP3 by ERK2 is dose dependent and saturable, we can determine both the dissociation constant between ERK2 and MKP3 and the extent of MKP3 activation from the concentration dependence of ERK2 on the MKP3-catalyzed pNPP reaction. Furthermore, we have developed a competitive assay to determine the binding affinity of fragments/domains of MKP3 that are important for ERK2 recognition. The rationale for this approach is that protein fragments/domains in MKP3 required for the ERK2-induced MKP3 activation should function as inhibitors of ERK2-induced MKP3 activation. With these assays, we were able to quantitatively evaluate the contributions that residues/regions within MKP3 make to ERK2
binding and ERK2-induced MKP3 activation (11) .
In the current study, we have identified structural elements in ERK2 that are important for binding and activation of MKP3 using the activation-and competition-based assays with wild-type MKP3 and various ERK2 mutants. In addition, we have unveiled structural features in ERK2 that mediate specific Elk1 recognition. Our results show that protein-protein interaction between ERK2 and its cognate regulators and substrates involve a bipartite recognition mechanism.
EXPERIMENTAL PROCEDURES
DNA Constructs and Site-Directed Mutagenesis. The coding sequence of ERK2 was subcloned into pET15b to yield the NH 2 -terminal (His) 6 -tagged ERK2. MKP3 with a C-terminal (His) 6 -tag in pET21a was described previously (11) . The cDNA for the constitutively active MEK1 (MEK1/G7B, i.e., MEK1/ 44-51/S218D/M219D/N221D/S221D) in pRSETa was kindly provided by Dr. Natalie Ahn. Oligonucleotide primers CATATGACTGAGATCACCCAACC (NdeI site underlined) and GGATCCTCATGGCTTCTG GGGCCC (BamHI site underlined)
were used to generate the NH 2 -terminal (His) 6 -tagged Elk1 (residues 307-428) by PCR using pGEX-2T/Elk-1-(307-428) (a generous gift from Dr. Kun-Liang Guan) as a template. The PCR product was subcloned into pET14b at NdeI/BamHI. Mutant ERK2 and MKP3 were generated by PCR reactions according to the standard procedure of the QuickChange TM site-directed mutagenesis kit (Stratagene) using either pET15b-(His) 6 -ERK2 or pET21a-MKP3-(His) 6 as a template. All mutants were verified by DNA sequencing.
Peptide Synthesis, Protein Expression and Purification. A synthetic peptide derived from
Elk1 (residues 387-399, Ac-RRP 387 RSPAKLSFQFPS 399 -NH 2 ), which contains an ERK2 phosphorylation site Ser389 (16) and an ERK2 docking site sequence FQFP (17) , was used in the competition-based assay. The Elk1 peptide was synthesized using standard protocol, purified by HPLC, and characterized by MALDI-TOF mass spectrometry by Alpha Diagnostic International.
The purity of the peptide was determined to be close to 100%. Wild-type and mutant NH 2 -terminal (His) 6 -tagged ERK2s, wild-type and mutant COOH-terminal (His) 6 -tagged MKP3s, NH 2 -terminal (His) 6 -tagged Elk1/307-428, and NH 2 -terminal (His) 6 -tagged MEK1/G7B were expressed in E. coli BL21/DE3 and purified using standard procedures of Ni
2+
-NTA agarose (QIAGEN) affinity purification as described previously (11) . Protein concentration was determined using the Bradford dye binding assay (Bio-Rad) diluted according to the manufacturer's recommendations with bovine serum albumin as standard.
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where A is the absorbance at 405 nm of the sample in the presence of ERK2, A 0 is the absorbance at 405 nm in the absence of ERK2, A ∞ is the absorbance at 405 nm when the concentration of ERK2 is infinite, C M is the MKP3 concentration which is fixed at 0.2 µM, C E is the ERK2 concentration during titration, and K d is the dissociation constant for ERK2 binding to MKP3.
To determine the affinity of Elk1 or MEK1 for ERK2, the competitive binding assay was used (11) . In this assay, the reaction was initiated by the addition of 0.1 µM MKP3 in a mixture (0.2 ml) containing 40 mM pNPP, 1.2 µM ERK2 and various concentrations of the Elk1 peptide, Elk1/307-428, or MEK1 at 30 °C and pH 7.0, in 50 mM 3,3-dimethylglutarate buffer, containing positively charged Arg or Lys residues that are important for ERK2 binding (6, 11, (18) (19) (20) (21) (22) (23) .
Deletion of the KIM sequence (residues 61-75) from MKP3 resulted in a 135-fold reduction in ERK2 binding affinity but did not affect MKP3's propensity to be activated by ERK2 (11) .
Recent data suggest that all ERK2 interacting proteins may bind ERK2 through electrostatic interactions between the positively charged KIM motif and a common docking (CD) domain in ERK2 composed of a stretch of negatively charged amino acids (e.g., Asp316 and Asp319) situated opposite to the kinase catalytic cleft (6) . Asp334 by an Asn (D334N) and activates several developmental pathways (24) . The same mutation in mammalian ERK2 (ERK2/D319N) appears to be resistant to inactivation by MKPs in transfected cells (25, 26) . Previous studies indicate that ERK2/D319N displays reduced affinity for MKP3 and is unable to activate the MKP3 phosphatase activity (6, 14) . However, using the quantitative activation-based assay, we were able to establish the K d of ERK2/D319N
for MKP3 (14.8 ± 1.2 µM), which is 87-fold larger than that of the wild-type ERK2 (11) . More importantly, we found that ERK2/D319N can activate MKP3 to the same level induced by the wild-type ERK2 when a saturating amount of ERK2/D319N is present in the reaction. Thus, like the KIM sequence in MKP3, Asp319 in ERK2 plays a major role in ERK2 binding to MKP3, but it is not essential for ERK2 induced MKP3 activation.
To further define the contribution of ERK2 CD domain to MKP3 binding and activation,
we determined the effects of amino acid substitutions in CD domain using the activation-based assay outlined in the Experimental Procedures. We chose amino acid residues in the vicinity of Asp319, based on both primary and tertiary structure. All experiments were performed at pH 7.0, ionic strength of 0.15 M, and 30 o C. As summarized in Table 1 , the dissociation constant (K d ) for ERK2 and MKP3 is 0.17±0.03 µM. No significant effects were observed for ERK2 mutants Q313E, S218D, E324A, and F329L. However, when Tyr126 and Tyr314 were replaced by an Ala, the affinity of ERK2/Y126A and ERK2/Y314A for MKP3 was reduced by 20 and 7.8-fold, respectively. When Asp160 and Asp316 was replaced by an Asn, the affinity of ERK2/D160N
and ERK2/D316N for MKP3 decreased 18 and 9.6-fold, respectively. Substitution of Glu79 or
Arg133 with an Ala reduced the affinity of ERK2/E79A and ERK2/R133A for MKP3 by 5.7 and 5.1-fold, respectively. Thus, Asp319 is the most important residue in ERK2 CD domain as large decreases (60-100-fold) in binding affinity were observed when Asp319 was changed to Ala, Asn, Glu, or Arg. Interestingly, ERK2/E324Q exhibited a 3.7-fold higher affinity for MKP3 than that of the wild-type ERK2. Taken together, our data suggest that the CD site is likely composed of residues Glu79, Tyr126, Arg133, Asp160, Tyr314, Asp316, and Asp319, which form a contiguous docking surface on the back side of the ERK2 kinase active site ( Figure 1A ). It is important to point out that although mutation of CD site residues decreased MKP3 binding affinity, none of them affected ERK2' ability to activate MKP3.
A "Hot Spot" Interaction between the KIM Sequence of MKP3 and the CD Site in ERK2.
It has been suggested that the CD site may make direct contact with the KIM sequence in ERK2 interacting molecules (6, 27) . We showed previously that when Arg64 and Arg65 in the KIM sequence of MKP3 were replaced by an Ala, the affinity of MKP3/R64A and MKP3/R65A for ERK2 decreased 7.3 and 150-fold, respectively (11) . Interestingly, the MKP3/R64K mutant displayed a K d value for ERK2 identical to that of the wild-type MKP3, indicating that a Lys can effectively replace an Arg at position 64 (Table 1 ). In contrast, the MKP3/R65K exhibited a binding affinity for ERK2 that was nearly 50-fold lower than that of the wild-type MKP3 and only 3-fold better than that of MKP3/R65A (Table 1 ). This result suggests that a guanidinium side chain is required at position 65 of MKP3 for high affinity binding with ERK2.
Since removal of side chains at Arg65 or Asp319 result in similar loss in binding affinity (150x for MKP3/R65A and 110x for ERK2/D319A), it is possible that Arg65 directly interacts with Asp319. Because Lys fails to substitute for Arg65 and Asn is unable to replace Asp319, the guanidinium group of Arg65 may engage in a bidentate H-bond with the carboxylate group of Asp319, in which the guanidinium group supplies two H-bond donors and the carboxylate group provides two H-bond acceptors. The importance of the optimal positioning between the side chains of Arg65 and Asp319 is highlighted by the large decrease in binding affinity experienced by the conservative mutant ERK2/D319E. The fact that swapping Arg65 and Asp319 simultaneously failed to restore the binding affinity between ERK2/D319R and MKP3/R65D
indicates that peripheral residues surrounding these two amino acids and the relative orientation by guest on http://www.jbc.org/ Downloaded from of MKP3 and ERK2 are also important for binding (Table 1) . Further supporting evidence for direct interaction between Arg65 and Asp319 came from the observation that switching Arg65 to Asp in MKP3 or changing Asp319 to Arg in ERK2 did not result in further decrease in binding affinity (Table 1) . Thus, the geometric complementarity between the side chains of Arg65 and Asp319 is likely responsible for the formation of a hot spot for high affinity ERK2/MKP3
binding. Indeed, both Arg and Asp residues are enriched in hot spots observed in protein-protein interactions (28) . The energetically less important residues in the CD site and KIM sequence likely surround the hot spot interactions and serve to occlude bulk solvent from the hot spot.
Substrate Recognition Region in ERK2 Is Involved in MKP3 Binding and Activation.
Although the interaction between CD and KIM is important for high affinity binding between ERK2 and MKP3, it is not essential for the ERK2-induced MKP3 activation. This suggests that, in addition to the CD domain, other regions in ERK2 are also required for specific MKP3
recognition. We discovered previously that the ERK2-induced MKP3 activation requires a putative ERK specific docking sequence F 364 TAP 367 localized in the C-terminus of MKP3 (11) .
Although mutation of this sequence reduces MKP3's affinity for ERK2 by less than 4-fold, this region is essential for ERK2 induced MKP3 activation. Interestingly, the putative ERK docking sequence FXFP can also be found in many ERK2 substrates (17, (29) (30) (31) . This raises the possibility that the substrate-binding site in ERK2 may also be involved in MKP3 binding and activation.
If the ERK2 substrate-binding region is required for MKP3 activation, then Elk1, a physiological substrate of ERK2, should be able to block the ERK2-induced MKP3 activation.
To test this hypothesis, we prepared an Elk1-derived peptide (residues 387-399, Ac-RRP 387 RSPAKLSFQFPS 399 -NH 2 ), which contain the PRSP phosphoacceptor sequence separated by four residues from the ERK2 docking sequence FQFP. We also prepared the C-terminal fragment of Elk1 (residues 307-428), which contains all of the ERK2 phosphorylation sites, the FQFP docking sequence, and a KIM sequence (residues 312-321, KGRKPRDLEL) (16, 30) .
Both the Elk1 peptide and Elk1/307-428 are excellent ERK2 substrates (17, 32, 33 (Figure 2A ).
Importantly, the Elk1 peptide and Elk1/307-428 can suppress the ERK2-induced MKP3
activation by 80 and 100%, respectively, at saturating peptide/protein concentrations. These results support our hypothesis that regions within ERK2 responsible for ERK2 substrate binding (as opposed to the CD site) may also play an important role in mediating ERK2-dependent MKP3 catalytic activation.
Mapping an Area in ERK2 That Is Important for MKP3 Binding and Activation. It is
tempting to speculate that the C-terminus of MKP3, including the sequence motif that resembles the FXFP sequence, may bind to ERK2 in a manner analogous to the way by which ERK2
substrates bind to ERK2. Unfortunately, the peptide/protein substrate-binding region in ERK2
has not been fully defined. There are no crystal structures available for ERK2/substrate complexes. However, based on structural comparison with the cAMP-dependent protein kinase, it has been proposed that the ERK2 substrate recognition groove may lie between α D and α G and that the kinase activation loop L12 and the large MAP kinase insertion (α 1L14 and α 2L14 ) may be involved in substrate recognition (34, 35) . Subsequent biochemical studies suggest that α D , L11, and L12 may be important for substrate recognition (36) (37) (38) . In addition, the sequence segment through L13 and α G in JNK2 has been shown to be important for c-Jun binding (39) . In the case of p38, two clusters of amino acids, one in the region defined by α D -L8-α E , and the other in β 6 -L10, are also implicated in substrate binding (40) . Finally, recent results from the Nishida group indicate that the ED site (defined by Glu160 and Asp161 in p38) located in L11 contributes to p38's specificity for MAP kinase activated protein kinases (7) . These structural and biochemical data provide an outline for the putative ERK2 substrate-binding region. To identify residues in the putative ERK2 substrate binding region that are important for MKP3 recognition and activation, we selectively replaced amino acids in α D , L8, α E , L9, β 6 , L10, β 7 , L11, L12, L13, and α G that are unique to ERK1/2 and/or surface accessible to Ala (Figure 3 ).
The functional significance of these residues in mediating specific MKP3 binding and activation were quantitatively evaluated using purified wild-type MKP3 and mutant ERK2s as described (11) . We first examined residues in α D -L8 (Table 2 ). Moderate effects (2-4 fold decrease in MKP3 binding affinity) were detected when Lys112, Leu113, Lys115, Thr116, Gln117, and
His118 were individually changed to Ala. With the exception of T116A, none of the residues are essential for the ERK2-induced MKP3 activation. Y111A and L119A exhibited a 4.9 and 5.5-fold decrease in MKP3 binding affinity, respectively, but retained the ability to fully activate MKP3.
We then focused on the region defined by α E , L9, β 6 , L10, β 7 , and L11 (residues 121-160). Although Tyr126 and Arg133 reside in α E , and Asp160 is part of L11, they are considered part of the CD site based on their proximity to Asp319 in the three dimensional structure ( Figure   1A and Table 1 ). No significant effects were observed for ERK2 mutants N121A, D122A, N152A, T157A, and T158A. Moderate decrease (2-5 fold) in binding affinity was observed for S151A and L154A, although neither failed to activate MKP3 at saturating concentrations. In contrast, although removal of the side chain from Lys149 had no effect on MKP3 binding affinity, K149A could only activate MKP3 to 67% of the phosphatase activity induced by wildtype ERK2.
Next, we studied residues located in α F , L13, and α G . As summarized in Table 2 , no significant effect was observed when Asn222 was changed to an Ala. Only moderate decrease (2-3.5 fold) in binding affinity was observed for I225A, P227A, and D233A, although none of them were essential for the ERK2-induced MKP3 activation. Strikingly, substitutions of Arg223, Lys229, and His230 with an Ala not only resulted in large decease in MKP3 binding affinity (13 to 49 fold) but also severely impaired ERK2's ability to activate MKP3-catalyzed pNPP reaction (Table 2) .
Finally, we made several substitutions in the putative P+1 site of ERK2 substrate binding region: T179A, E184G, T188A, R189A, and W190A. We also replaced Ser264 in the MAP kinase insert with an Ala. No significant effects were observed for E184G, T188A, and S264A
( Table 2 ). T179A and W190A exhibited a 4 and 6-fold decrease in MKP3 binding affinity, respectively, but retained the ability to fully activate MKP3. In contrast, although ERK2/R189A displayed the same affinity for MKP3 as the wild-type ERK2, it was only able to activate MKP3
to 70% of the maximum activity even at saturating ERK2/R189A concentrations. Collectively, the results suggest that in addition to the CD site, α D , L8, L10, L11, L12, α F , and L13, are also involved in MKP3 recognition. Specifically, residues Tyr111, Leu119, and Trp190 contribute significantly (>5-fold) to high affinity MKP3 binding, whereas residues Thr116, Lys149, Arg189, Glu218, Arg223, Lys229, and His230 are important for the ERK2-induced MKP3 activation. These residues form a novel binding surface area away from the CD site and adjacent to the active site cleft that binds ATP ( Figure 1C ).
Identification of ERK2 Residues Important for Elk1
Recognition. The results described above suggest that in addition to the CD site, the putative ERK2 substrate-binding region may also be involved in MKP3 binding and activation. In order to confirm that the putative substratebinding region is indeed important for ERK2 substrate recognition and to identify amino acid residues that are important for ERK2 substrate phosphorylation, we determined the kinase activity of the ERK2 mutants using both myelin basic protein (MBP) and the transcription factor Elk1 as substrates. MBP is a widely used protein substrate for several protein kinases, including ERK2 (41). The transcription factor Elk1 is a physiological substrate of ERK2. When phosphorylated by ERK2, Elk1 forms a complex with the serum response factor and binds the serum response promoter element to enhance transcription from the c-fos promoter. The kinase activity of ERK2 was determined by a radioisotope assay in which the rate of 32 P incorporation from (γ-32 P) ATP into a substrate was directly measured (see Experimental Procedures). All steady-state kinetic measurements were performed at pH 7.4 and 30 o C in 1 mM ATP, which is within the range of physiological ATP concentrations. We determined the kinetic parameters, k cat and K m , for the wild type and mutant ERK2s with both MBP and Elk1/307-428 as a substrate (Table 3) . The values for the overall catalytic efficiency, also known as substrate specificity constant k cat /K m , are also listed in Table 3 .
As shown in Table 3 , substitutions in the CD site and the putative substrate-binding region in ERK2 produce very small changes in the kinetic parameters for the ERK2-catalyzed MBP phosphorylation (< 5-fold for most ERK2 mutants). This is consistent with the fact that MBP contains neither a KIM motif nor an FXFP docking sequence. The only exception is D233A, which displays a k cat /K m value 20-fold lower than that of the wild-type ERK2. The modest effects on MBP phosphorylation suggest that mutations in the CD site and the putative substrate-binding region do not introduce gross conformational changes in the ERK2 catalytic site and the overall structure. Since Elk1/307-428 possesses both KIM and FXFP sequences, much larger changes (i.e., >5-fold) in the kinetic parameters for Elk1 phosphorylation were observed for a number of ERK2 mutants (Table 3) . Indeed, many residues in the CD site important for MKP3 binding (e.g., Glu79, Asp160, Tyr314, Asp316, and Asp319) are also involved in Elk1 recognition. Moreover, a subset of residues (i.e. Tyr111, Arg189, Trp190, Arg223, Lys229, and His230) in the putative substrate binding region shown to be critical for MKP3 binding and activation are also important for Elk1 phosphorylation. Substitution of these residues with Ala led to 16-130 fold decrease in the k cat /K m values for the ERK2-catalyzed Elk1 phosphorylation. These results indicate that the protein-protein interaction surfaces between ERK2 and MKP3 may overlap with those between ERK2 and Elk1, consistent with Elk1's ability to block the ERK2-induced MKP3 activation (Figure 2A ).
Besides residues that are required for both MKP3 and Elk1 binding, there are additional residues that are unique to either MKP3 or Elk1 recognition. For example, Tyr126 and Arg133 in the CD site are required for MKP3 but not Elk1 binding ( Figure 1A ). In contrast, Thr157 and Thr158 are not essential for MKP3 binding but may constitute a part of the CD site for Elk1
( Figure 1B) . Moreover, a large reduction in k cat /K m (10-100 fold) was observed when the side chains of Leu113, Lys115, His118, Asp233, I225, Pro227, and Ser264 were replaced with an Ala (Table 3) , while the same mutations had little effect on ERK2's ability to bind and/or activate MKP3 ( Table 2) . On the contrary, substitutions at Thr116, Leu119, Lys149, and Glu218 resulted in severe impairment of MKP3 binding and activation (Table 2) , while the corresponding mutations had very minor effects on Elk1 phosphorylation (Table 3) . These results strongly suggest that the observed mutational effects are unlikely due to nonspecific structural perturbations. The similarities and differences between the novel MKP3 and Elk1 binding region are highlighted in Figure 1 C&D.
Although large decrease in Elk1 phosphorylation activity was also observed when Asn152 and Leu154 in β 7 were replaced with an Ala, the observed mutational effects on Elk1 phosphorylation may simply result from perturbations of ATP binding due to their proximity to the ATP binding pocket (34) . Consequently, Asn152 and Leu154 are not considered as part of the binding pocket for protein substrates. Possible structural changes caused by mutations in these residues are likely local because removal of side chains from Asn152, and Leu154 do not affect MKP3 binding and activation. Finally, in addition to mutations that reduce the ERK2 kinase activity, there are several ERK2 mutants (E58Q, D122A, S151A, and S221A) that display increased kinase activity (3-7 fold) against both MBP and Elk1 (Table 3) .
MKP3 and MEK1 Binding to ERK2 Is Mutually Exclusive.
In addition to the complexes formed with its substrates (e.g., Elk1) and inactivators (e.g., MKP3), ERK2 is also capable of forming a stable complex with its activator MEK1 (6). Kinetic analysis shows that the combined effect of deleting residues 44-51 and phosphorylation site substitutions mimic conformational changes normally induced by phosphorylation (42) . As shown in Figure 2B , unlike Elk1/307-428, MEK1/G7B exerts no significant effect on the ERK2-induced MKP3 activation even at concentrations up to 32 µM under the same conditions used for Elk1/307-428. The result is consistent with two scenarios. It is possible that MEK1/G7B shares the same binding sites with MKP3 with a much lower affinity for ERK2. If this is the case, the binding affinity of MEK1/G7B for ERK2 should be lower than that of Elk1/307-428, because the latter at 30 µ M could block the ERK2-induced MKP3 activation by 70% (Figure 2 ).
Alternatively, ERK2 can simultaneously associate with both MEK1/G7B and MKP3 to produce a ternary complex and the binding of MEK1/G7B to ERK2 does not influence the ability of ERK2 to activate MKP3.
In order to differentiate these two possibilities, we carried out GST-ERK2 pull-down experiments to measure MKP3 and MEK1/G7B binding to ERK2 directly. In the first experiment GST-ERK2 (10 µg) was used to bind (His) 6 -tagged MKP3 and MEK1/G7B. The amount of MKP3 or MEK1/G7B associated with ERK2 was visualized by anti-(His) 6 antibody (for details see Experimental Procedures). Consistent with early observations, both MEK1/G7B
and MKP3 are capable of binding ERK2 ( Figure 4A , lanes 3-6), although it is clear that more MEK1/G7B is needed to yield the same amount of ERK2 complex. More ERK2•MKP3 complex was formed than ERK2•MEK1/G7B when an equal amount (2 or 10 µg) of MKP3 and MEK1/G7B were used in the GST-ERK2 pull-down experiments ( Figure 4A, lanes 7 & 10) .
These results indicate that MKP3 binds to ERK2 with a higher affinity than MEK1/G7B does.
Moreover, the amount of MKP3 associated with ERK2 is decreased in the presence of MEK1/G7B, while the presence of MKP3 also decreases the amount of MEK1/G7B bound to ERK2 ( Figure 4A, lanes 8 & 9) . This result suggests that the binding of MKP3 to ERK2
interferes with the association of MEK1/G7B with ERK2, possibly through competition for the same binding sites.
To further investigate the binding interactions among MKP3, MEK1/G7B, and ERK2, we also used GST-MKP3 as a pull-down reagent. We determined that MEK1/G7B do not form a complex with MKP3 when 20 µg of MEK1/G7B is mixed with 10 µg of GST-MKP3 ( Figure 4B , lane 3). In contrast, strong complex (ERK2•MKP3) formation is observed when 10 µg GST-MKP3 is mixed with 2 µg of ERK2 ( Figure 4B, lane 4) . If ERK2 were able to simultaneously bind both MKP3 and MEK1/G7B to make a ternary complex, then GST-MKP3 should be able to pull down both ERK2 and MEK1/G7B (through its interaction with ERK2) when the three proteins were incubated together. As shown in Figure 4B , no MEK1/G7B is detectable from the ERK2•MKP3 complex pulled down by GST-MKP3. Rather, the amount of ERK2 associated with GST-MKP3 decreases with increasing amount of MEK1/G7B ( Figure 4B, lanes 4-7) . Since MEK1/G7B does not bind MKP3, the decreased binding between ERK2 and MKP3 in the presence of MEK1/G7B most likely results from competition by MEK1/G7B and MKP3 to the same binding sites in ERK2. Since ERK2 is still able to form complex with MKP3 in the presence of 10-fold excess of MEK1/G7B, the affinity of MKP3 for ERK2 is higher than that of MEK1/G7B. Collectively, the results shown in Figure 4 suggest that ERK2 displays a higher binding affinity for MKP3 than MEK1/G7B, and that the binding of MKP3 and MEK1/G7B to ERK2 is mutually exclusive. The regulation of ERK2 activity by MKP3 provides a good example for the importance of proper protein-protein interaction in MAP kinase signaling. MKP3 forms a physical complex with ERK2 and is highly specific for ERK2 inactivation (12, 13) . Interestingly, purified recombinant ERK2 stimulates the phosphatase activity of MKP3 toward pNPP (14) . Moreover, catalytic activation by MAP kinases has also been observed with other MKPs which mirrors the substrate selectivity of MKPs (12, 13) . Biochemical and structural evidence suggest that the active site and general acid loop in MKP3 are deformed in the absence of ERK2 (9, 15, 43, 44) .
The binding of ERK2 to MKP3 must repair these defects and induce MKP3 to assume an active conformation for ERK2 dephosphorylation (9, 10, 15) . These observations suggest a general mechanism by which all members of the MKP family are regulated: the MKPs exist in latent and inactivate states, and upon association with specific MAP kinases, the MKPs are activated leading to selective inactivation of MAP kinases.
To begin to elucidate the molecular basis for specific MKP3 recognition and activation by ERK2, we have carried out a systematic mutational and deletion analysis of MKP3 to quantitatively evaluate the contributions that residues/regions within MKP3 make to ERK2
binding and ERK2-induced MKP3 activation (11 The KIM sequence characterized by a cluster of positively charged residues has been found in many ERK2 binding proteins, including its regulators and substrates (6, 11, (18) (19) (20) (21) (22) (23) .
There is evidence suggesting that the KIM sequences in ERK2-binding proteins compete for binding to the same CD domain in ERK2 (residues 311-324), which is decorated with several acidic residues (6, 27) . However, it is clear that the KIM-CD interaction alone cannot account for the docking specificity of ERK2 interacting molecules (6) . In addition to the KIM sequence (also called D-domain in certain ERK2 substrates), many ERK2 substrates (e.g., transcription factors, KSR, and PDE) also have an FXFP docking motif (17, (29) (30) (31) , whose binding pocket on ERK2
remains to be defined. Interestingly, we noted that similar FXFP sequences are also in MKPs that are capable of inactivating ERK2 and that the FXFP motif is essential for the ERK2-induced MKP3 activation (11) . Thus, our working hypothesis is that the binding of ERK2 to MKP3 and the subsequent ERK2-induced MKP3 activation may be distinct events. The interaction between MKP3 KIM motif and the CD site in ERK2 may be important for high affinity binding, but additional interactions with MKP3's FXFP motif involving other regions of ERK2 (e.g., the ERK2 substrate binding groove) may be required for MKP3 to adopt a catalytically active conformation.
To test our hypothesis, we have mapped the ERK2-MKP3 interaction surfaces in ERK2
by systematically mutagenizing and characterizing amino acids in and around the CD domain as well as in the putative substrate-binding regions. We have uncovered a contiguous surface area (termed the CD site) including the CD domain responsible for high-affinity MKP binding and provided new insight into the interaction between the KIM sequence and the CD site. We have also identified a novel surface area away from the CD site that are important for MKP3
activation. The results support our hypothesis that specific MKP3 recognition and activation by ERK2 involves multiple regions of ERK2. As an added value, we have also identified regions in share many of the same amino acids (e.g., Glu79, Asp160, Tyr314, Asp316, and Asp319), they also contain residues that are unique to each target (e.g., Tyr126 and Arg133 for MKP3, and Thr157 and Thr158 for Elk1) (Figure 1 A&B) . Interestingly, Thr157 and Thr158 correspond to the ED site needed for docking interactions of p38 with several MAP kinase activated protein kinases (6) . It is possible that the CD site for MAP kinases include both the CD domain and the ED site, which is consistent with the docking groove hypothesis (6).
The most important residue in the CD site for both MKP3 and Elk1 recognition is Asp319 (Tables 1 & 3) , while the most important residue in the KIM sequence of MKP3 is Arg65 (11). Systematic mutagenesis analyses of both Asp319 and Arg65 (Table 1) suggest that these two residues may directly interact with each other, contributing to an energetic "hot spot"
in the protein-protein binding interface. It is likely that the guanidinium group of Arg65 in MKP3 may engage in a bidentate H-bond with the carboxylate group of Asp319 in ERK2, in which the guanidinium group supplies two H-bond donors and the carboxylate group provides two H-bond acceptors. However, it is of interest to note that the proposed electrostatic interactions between the basic residues in the KIM sequence and the acidic residues in the CD domain (6; and this study) were not observed in the structures of p38 in complex with KIM peptides derived from substrate MEF2 and activating enzyme MKK3b (45) . Instead, the structures highlight hydrophobic interactions between the KIM peptides with a docking groove (between α helices α D and α E and the reverse turn between β 7 and β 8 ) near to the ED site. It is possible that different KIM sequences may bind MAP kinases in slightly different modes.
Alternatively, the interactions observed in the p38 and KIM peptide structures may differ from those in the intact protein complexes. Clearly, high-resolution crystal structures of intact protein complexes are needed to fully elucidate the precise contacts between MAP kinase and its interacting proteins.
The Novel MKP3 Binding and Activation Site and the Substrate-Binding Site for Elk1.
Although the interaction between the KIM sequence and the CD site is important for highaffinity ERK2 binding to MKP3, it is not essential for the ERK2-induced MKP3 activation (11, and Table 1 ). Interestingly, substitution of the FXFP sequence in MKP3 by Ala residues reduces ERK2 binding affinity 4-fold yet the mutant can only be activated to 32% of the wild-type MKP3 (11) . Since the FXFP motif is present in many ERK2 substrates and is adjacent and Cterminal to the phosphoacceptor, it raises the possibility that the ERK2 substrate-binding region may also be involved in MKP3 binding and activation. Indeed, both an Elk1-derived peptide (residues 387-399), which contains both the phosphoacceptor sequence and the FQFP motif, and a C-terminal fragment of Elk1 (residues 307-428), which contains all of the ERK2 phosphorylation sites, the FQFP docking motif, and a KIM sequence, can effectively block the ERK2-induced MKP3 activation (Figure 2A) . Furthermore, the involvement of putative ERK2
substrate-binding region in MKP3 activation was also implicated from biochemical analysis of a panel of ERK2/p38 chimeric molecules (23). Thus, it is possible that some structural elements in Unfortunately, the ERK2 substrate-binding area has not been fully defined. In order to identify additional factors in ERK2 that contribute to specific MKP3 binding and activation, we have carried out systematic mutagenesis and biochemical analysis of amino acid residues located in regions previously suspected to be involved in MAP kinase substrate recognition. The ERK2 mutants were quantitatively analyzed for their ability to bind MKP3 and for their ability to activate MKP3 (Table 2 ). In addition, the ERK2 mutants were also analyzed for their ability to phosphorylate Elk1 in order to determine if the putative ERK2 substrate-binding site is also important for Elk1 recognition ( Table 3 ). Most of the residues selected for mutagenesis have their side chains exposed on the surface, and therefore, their mutations are predicted not to significantly affect the hydrophobic core or the structural integrity of the ERK2 protein. None of the resides have direct contact with catalytically essential residues such as Lys52, Asp147, and
Asp165. Indeed, with the exception of Asp233, substitutions of these residues do not significantly affect the ERK2-catalyzed phosphorylation of MBP, a nonspecific substrate (Table   3) . Thus, the measured differences in binding and functional activity for the mutants, compared
to the wild type, should directly reflect the contributions of particular residues to target recognition of ERK2.
Our results show that Tyr111 in α D , Leu119 in L8, and Trp190 in L12 contribute to highaffinity binding to MKP3 (Table 2 ). More importantly, our results also reveal that Thr116 in α D , Lys149 in L10, Arg189 in L12, and Glu218 in α F are essential for the ERK2-induced MKP3 activation, while Arg223, Lys229, and His230 in L13 are required for both high-affinity MKP3
binding and the ERK2-induced MKP3 activation (Table 2) . Together, these residues form a novel MKP3 binding and activation site away from the CD site ( For example, Asp319 in the CD site is mutated to Asn in the sevenmaker mutant of Drosophila ERK/Rolled, which displays a gain-of-function phenotype (24) . We determined that the affinity of ERK2/D319N for MKP3 is 87-fold lower than that of the wild type. It has been proposed that the increased signal sensitivity of the ERK2/D319N mutant is due to a decreased sensitivity to dual specificity phosphatases such as MKP3 (14, 25, 26) . ERK2/D160N represents another dominant gain-of-function mutation in the Drosophila MAP kinase, termed rl Su14 (46) . interacting proteins as well, we should emphasize that the observed phenotype may be the result of a compounded effect on all ERK2 interactions in the cell.
In addition to mutations that reduce the ERK2 kinase activity, there are several ERK2 mutants (E58Q, D122A, S151A, and S221A) that display increased kinase activity (3-7 fold) against both MBP and Elk1 (Table 3) . In many cases, the increase in activity results largely from an elevated k cat . Interestingly, the corresponding E58Q mutation in Saccharomyces cerevisiae FUS3 MAP kinase (D48N) exhibits a dominant gain-of-function mutation phenotype (47) . and Elk1 to ERK2 is mutually exclusive and are consistent with Elk1's ability to block the ERK2-induced MKP3 activation (Figure 2A ). Our data also suggest that the binding of MKP3
and MEK1 to ERK2 is also mutually exclusive ( Figure 4 ). It is possible that ERK2 also uses both the CD site and the substrate-binding region for MEK1 binding. Consistent with this hypothesis, the KIM sequence in MEK1 competes for the same CD site identified in this study (6, 27) . In addition, there is also evidence suggesting an essential role for residues in α G and the MAP kinase insert in the interaction of ERK2 with MEK1 (49). The region defined by α G and the MAP kinase insert overlap with the Elk1 substrate-binding site defined in this study (Table 3 and Figure 1D ).
Although MEK1, MKP3, and Elk1 bind ERK2 in an mutually exclusive manner, they possess different binding affinity for ERK2. We determined that the K d values of MKP3 and Elk1 for ERK2 are 0.17 and 2.1 µM, respectively. In addition, our data indicate that the affinity of MKP3 and Elk1 for ERK2 is higher than that of MEK1 (Figures 2 & 4) . This difference in ERK2 binding affinity and the mutual exclusivity in ERK2 association are consistent with the order of ERK2 signaling events. The association of ERK2 with MEK1 in the cytosol leads to ERK2 phosphorylation and activation. The activated ERK2 is then sequestered from MEK1 by its substrates for phosphorylation. Since the expression of many MKPs is induced by ERK2 activation, the higher affinity of MKPs for ERK2 ensures efficient termination of ERK2 signaling after MKP induction.
A Bipartite Modular Model for ERK2 Interaction with Its Cognate Regulators and
Substrates. We propose that the efficiency and fidelity of ERK2 signaling is achieved by a bipartite recognition process ( Figure 5 ). In this model, one part of the ERK2 binding proteins (e.g., the KIM sequence) docks to the CD site located on the back side of the ERK2 catalytic pocket for high-affinity association. The major function of the KIM/CD interaction may be to Residue numbering, secondary structure designation, and sub-domains are for ERK2 as defined in (34) . Residues in the black boxes represent absolutely invariant residues among MAP kinases and residues in shaded boxes indicate conserved substitutions. substrates. ERK2 uses two distinct surface areas, the CD site (indicated by a blue oval) and the Table 1 Contributions of residues in ERK2 CD site to MKP3 binding and activation. Table 2 Contributions of residues in the putative ERK2 substrate recognition region to MKP3 binding and activation. Figure 1 by guest on http://www.jbc.org/ Downloaded from Figure 2 
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